Clinical Trials
372 trialsCryotherapy in Combination with Red Light PDT for Actinic Keratosis of Full Face
Psoriasis Treatment Center of Central New Jersey
The Efficacy and Safety of Liangxue Ointment in the Treatment of Hand-foot Syndrome Caused by VEGFR-TKI Drugs
Peking University Cancer Hospital & Institute
Ipilimumab and Nivolumab Followed by Adjuvant Nivolumab in Locally Advanced or Limited Metastatic Melanoma
European Institute of Oncology
Trimelvax001
University of Chile
iToBoS
The University of Queensland
Mogamulizumab Q4week Dosing in Participants With R/R CTCL
Kyowa Kirin Co., Ltd.
NIVOPTIMIZE
Erasmus Medical Center
Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma
Northwestern University
Dermatoscopy Guided Resection for Skin Cancer
Region Örebro County
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
NGM Biopharmaceuticals, Inc
Study сomparing the Efficacy and Safety of RPH-075 and Keytruda® in Patients With Unresectable or Metastatic Skin Melanoma
R-Pharm
Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms
R-Pharm
A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies
AO GENERIUM
SNMM
Eye & ENT Hospital of Fudan University
Identification of Oral Lesions Through an Autofluorescence System
Federico II University
ECOBASO
Damae Medical
A Study of RC48-ADC in Advanced Melanoma Subjects With HER2 Variant (Mutation, Amplification, Overexpression)
RemeGen Co., Ltd.
Leaderboard Influence on Self-Regulated Training in a Gamified Dermoscopy Training App
Herlev Hospital
BMUMM
Centre Hospitalier Universitaire de Nice
Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies
TopAlliance Biosciences
ERK Inhibitor JSI-1187 in Advanced Solid Tumors
JS InnoPharm, LLC
MINI-MD
University Hospital Rijeka
Skin Tumor Biomarkers by Mass Spectrometry Imaging
Bispebjerg Hospital
Autologous CD8+ SLC45A2-Specific T Lymphocytes With Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma
M.D. Anderson Cancer Center
Shadow4All
Universidade do Porto
Quantitative Analysis of PET/CT Images of Immune Related Side Effects in Metastatic Melanoma Patients
Institute of Oncology Ljubljana
CELEBRATE
Peter MacCallum Cancer Centre, Australia
The Efficacy and Safety of Using Intralesional 5-fluorouracil for Basal Cell Carcinoma
University of Aleppo
ACTME
Leiden University Medical Center
PV-10 in Combination With Pembrolizumab for Treatment of Metastatic Melanoma
Provectus Pharmaceuticals
Negative-pressure Wound Therapy on Full-thickness Skin Grafts of the Lower Leg
Helsinki University Central Hospital
New Treatments for Actinic Keratoses of the Scalp
Helsinki University Central Hospital
OpACIN-neo
The Netherlands Cancer Institute
Study of an Artificial Human Skin Medicine for Patients With Basal Cell Carcinoma Undergoing Reconstructive Surgery
Andalusian Network for Design and Translation of Advanced Therapies
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
OncoResponse, Inc.
RegoMel
Universitair Ziekenhuis Brussel
UPLIFT
Massachusetts General Hospital
FLARE
University of Utah
AIDMel
Karolinska University Hospital
DUNCAN
Philogen S.p.A.
IntriNSiC
Philogen S.p.A.
Imatinib Mesylate in Combination With Pembrolizumab in Patients With Melanoma
Keio University
Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy
Massachusetts General Hospital
IMPulse
Centre Hospitalier Universitaire Vaudois
A Phase I Trial of SIM1811-03 in Subjects With Advanced Tumors
Jiangsu Simcere Pharmaceutical Co., Ltd.
Clinical Study of the Efficacy and Safety of BCD-201 and Keytruda in Subjects With Advanced Melanoma
Biocad
Phase I/II Study of Linperlisib Plus Chidamide for R/R Cutaneous T-cell Lymphoma: a Prospective, Single-center Study
Peking Union Medical College Hospital
Neo Trio
Melanoma Institute Australia
Topical Ascorbic Acid for Treatment of Squamous Cell Skin Cancer
Center for Biomedical Research, Inc.
CAcTUS
The Christie NHS Foundation Trust